Zurueck zur Suche

Reporte zur Charge EL 3249 5-21

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MO 2

VAERS 967996

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EL 3249 5-21

mild
Staat
MO
Alter
64,0
Geschlecht
F
Eingang
08.02.2021
Impfdatum
20.01.2021
Beginn
22.01.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Diarrhoea Haematochezia Abdominal pain Abdominal pain lower

Symptomtext

Severe lower stomach cramps; diarrhea; some bloody stool; This is a spontaneous report from a contactable other healthcare professional reported for herself. A 64-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL32495-21), via an unspecified route of administration at Left arm on 20Jan2021 14:15 at single dose for COVID-19 immunization. Medical history included allergies to penicillin, allergies to Latex and allergies to shellfish. Concomitant medication included rosuvastatin calcium (CRESTOR), raloxifene hydrochloride (EVISTA), tramadol, ibuprofen 600 mg received within 2 weeks of vaccination. The patient previously took iodine and experienced allergies to Iodine, codeine and experienced allergies to codeine, oxytetracycline (TERRAMYCIN) and experienced allergies to Terramycin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe lower stomach cramps and diarrhea since 22Jan2021 19:30 and still having this issue to include some bloody stool on 22Jan2021 12:30. No treatment received for the events. The events were reported as non-serious. The patient was not pregnant. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Latex allergy; Penicillin allergy; Shellfish allergy
Andere Medikamente
CRESTOR; EVISTA; TRAMADOL; IBUPROFEN
Allergien
-
Vorherige Impfungen
-

VAERS 967996

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EL32495-21

mild
Staat
MO
Alter
64,0
Geschlecht
F
Eingang
08.02.2021
Impfdatum
20.01.2021
Beginn
22.01.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Diarrhoea Haematochezia Abdominal pain Abdominal pain lower

Symptomtext

Severe lower stomach cramps; diarrhea; some bloody stool; This is a spontaneous report from a contactable other healthcare professional reported for herself. A 64-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL32495-21), via an unspecified route of administration at Left arm on 20Jan2021 14:15 at single dose for COVID-19 immunization. Medical history included allergies to penicillin, allergies to Latex and allergies to shellfish. Concomitant medication included rosuvastatin calcium (CRESTOR), raloxifene hydrochloride (EVISTA), tramadol, ibuprofen 600 mg received within 2 weeks of vaccination. The patient previously took iodine and experienced allergies to Iodine, codeine and experienced allergies to codeine, oxytetracycline (TERRAMYCIN) and experienced allergies to Terramycin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe lower stomach cramps and diarrhea since 22Jan2021 19:30 and still having this issue to include some bloody stool on 22Jan2021 12:30. No treatment received for the events. The events were reported as non-serious. The patient was not pregnant. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Latex allergy; Penicillin allergy; Shellfish allergy
Andere Medikamente
CRESTOR; EVISTA; TRAMADOL; IBUPROFEN
Allergien
-
Vorherige Impfungen
-